Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
about
Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.Precision medicine in pediatric oncology.WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma.Patient-derived xenografts as preclinical neuroblastoma models.ALK in Neuroblastoma: Biological and Therapeutic Implications.Treatment and outcome of adult-onset neuroblastoma.CHL1 gene acts as a tumor suppressor in human neuroblastoma.
P2860
Q38716908-7A254652-8553-4287-914A-5308D39AD833Q47392557-A5221BC8-FD0C-4594-A1DF-E01A35EEA035Q47618158-3F3DB1AD-E425-4696-9485-07FDA3E3F2DCQ50027944-700553EE-5EEA-4741-8288-09B0A64AE4AAQ52324760-1588D77D-401C-46D6-84E5-1A235BB5416CQ52637916-F8CD7D0F-888A-44FA-8B96-760AFDF91883Q55039402-17CFDCBA-2108-467E-9AB4-EC5383DE1101
P2860
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
@ast
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
@en
type
label
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
@ast
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
@en
prefLabel
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
@ast
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
@en
P2093
P2860
P50
P1433
P1476
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome
@en
P2093
Irina Ostrovnaya
John M Maris
Kaitlyn R Rubnitz
Olivia M Padovan-Merhar
Siraj M Ali
Vincent A Miller
Yael P Mossé
P2860
P304
P356
10.1371/JOURNAL.PGEN.1006501
P577
2016-12-20T00:00:00Z